Exploring New Frontiers: Innovative Drug Combinations and Clinical Trials in Myelofibrosis Care
https://vimeo.com/1002800626 Myeloproliferative neoplasm (MPN) expert Dr. Abdulraheem Yacoub shares updates about additions in MPN treatment options, expansions in combination treatment options, and patient advice for locating clinical trials. [ACT]IVATION TIP “…keep up…
Overcoming Barriers: Ensuring Equitable Access to Myelofibrosis Care and Clinical Trials
https://vimeo.com/1001814577 How can barriers to optional myelofibrosis care be overcome? Expert Dr. Abdulraheem Yacoub discusses common barriers that patients encounter, support and financial solutions to overcome barriers, and proactive patient advice. [ACT]IVATION…
How Can Rural Physicians Improve Myelofibrosis Identification and Referrals?
https://vimeo.com/1001814225 How can myelofibrosis be better identified and referred by PCPs? Expert Dr. Abdulraheem Yacoub discusses strategies for rural myelofibrosis care, partnerships between hematology centers and community oncologists, and patient advice for…
Bridging the Gap | Enhancing Access to Specialized Myelofibrosis Care for Rural Patients
https://vimeo.com/1002791846 How can specialized myelofibrosis care be enhanced for rural patients? Expert Dr. Abdulraheem Yacoub from the University of Kansas Medical Center discusses solutions to bridge gaps in myelofibrosis care and patient…
Engaging in Myelofibrosis Shared Decision-Making | How Patients Can Collaborate With Healthcare Providers in Treatment
https://vimeo.com/1001813738 How can myelofibrosis patients engage in shared decision-making? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses ways for patients to collaborate with healthcare providers to determine the optimal treatment approach…
Managing Myelofibrosis for Patients Living Far From Specialists
https://vimeo.com/1001813824 Myelofibrosis expert Dr. Michael Grunwald from Levine Cancer Institute discusses strategies for patients living far away from specialists, how often blood checks should be performed, and proactive patient advice. [ACT]IVATION TIP…
Harnessing Community Resources to Support Rural Myelofibrosis Patients
https://vimeo.com/1001813005 How can community resources be utilized to support rural myelofibrosis patients? Expert Dr. Michael Grunwald from Levine Cancer Institute shares his perspective and how conversations with providers can be enriched. [ACT]IVATION…
Leveraging Telemedicine to Manage Myelofibrosis in Rural Areas | Overcoming Distance and Accessibility Challenges
https://vimeo.com/1001813133 How can telemedicine be leveraged to aid myelofibrosis patients in rural areas? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses methods used to help manage care of rural myelofibrosis patients,…
Helping Rural Doctors Recognize Myelofibrosis | How Patients and Providers Can Work Together
https://vimeo.com/1001812884 How can myelofibrosis patients and providers collaborate in helping rural doctors? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses common myelofibrosis symptoms and proactive patient advice for educating themselves and…
Barriers to Accessing Specialized Myelofibrosis Care in Rural Areas | Challenges and Solutions
https://vimeo.com/1001812407 What are common myelofibrosis care barriers in rural areas? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses barriers that myelofibrosis patients in rural areas encounter and solutions for overcoming barriers…
Novel Therapies and Clinical Trials for Myelofibrosis | Updates and Innovations
https://vimeo.com/1001812578 What’s the latest in higher risk myelofibrosis novel therapies and clinical trials? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses JAK inhibitors and other research updates along with proactive patient…
How Does Risk Stratification Shape Myelofibrosis Treatment?
https://vimeo.com/1000239081 What is involved in determining low risk versus high risk myelofibrosis? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses IPSS, DIPSS, MYSEC-PM, and MIPSS70 scoring systems, key patient factors they…